Teladoc Health Reports Second-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Teladoc (TDOC) PT Lowered to $40 at JPMorgan, 'We expect the stock to be a show-me story in the near term'
July 28, 2022 12:26 PM EDTJPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $40.00 (from $53.00) while maintaining a Neutral rating.
The analyst comments "We highlight a significant market opportunity for telehealth services, which helps to solve two key issues affecting the... More
Teladoc (TDOC) Misses Q2 EPS
July 27, 2022 4:07 PM EDTTeladoc (NYSE: TDOC) reported Q2 EPS of ($19.22), which may not compare to the analyst estimate of ($0.64). Revenue for the quarter came in at $592.4 million versus the consensus estimate of $587.71 million.
GUIDANCE:
Teladoc sees Q3 2022 EPS of ($0.85)-($0.60), versus the consensus... More
